Previous Close | 48.77 |
Open | 48.40 |
Bid | 47.00 x 0 |
Ask | 47.19 x 0 |
Day's Range | 45.42 - 49.09 |
52 Week Range | 12.71 - 67.45 |
Volume | 427,410 |
Avg. Volume | 215,481 |
Market Cap | 5.632B |
Beta (5Y Monthly) | 1.44 |
PE Ratio (TTM) | 71.04 |
EPS (TTM) | 0.66 |
Earnings Date | May 18, 2021 - May 24, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
It’s quite likely national marijuana laws will be reformed sometime this year. Fortunes will be made and lost here no doubt. But more importantly, lives won’t be ruined over smoking something that through capricious historical precedents became verboten.
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), today announced the closing of its previously announced marketed public offering of 5,000,000 subordinate voting shares in the United States and Canada (the "Offering") at a public offering price of C$50.00 per share ($39.63 per share after giving effect to the conversion rate published by Bloomberg at 4:30pm ET on April 7, 2021 to convert Canadian dollars to U.S. dollars). In connection with the closing of the Offering, the underwriters exercised in full their option to purchase an additional 750,000 subordinate voting shares. As a result, the gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by Trulieve, were C$287.5 million (or $227.9 million after giving effect to the conversion rate denoted above).
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), today announced the pricing of a marketed public offering of 5,000,000 subordinate voting shares in the United States and Canada (the "Offering") at a public offering price of C$50.00 per share ($39.63 per share after giving effect to the conversion rate published by Bloomberg at 4:30pm ET on April 7, 2021 to convert Canadian dollars to U.S. dollars). The gross proceeds to Trulieve from the offering are expected to be approximately $198.1 million, before deducting the underwriting discounts and commissions and other offering expenses. Trulieve has granted the underwriters a 30-day option to purchase up to an additional 750,000 subordinate voting shares at the public offering price, less the underwriting discounts and commissions.